
Zai Lab Ltd
ZLABNasdaqCIK 1704292HealthcareFiscal year ends Dec 31
Reports and events: 165 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-04-2808:04 ET | DEF 14A | Proxy statement | 0001628280-23-013769 |
| 2023-03-3106:09 ET | 8-K | 8.01 Other events | 0001628280-23-010007 |
| 2023-03-0116:11 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001628280-23-005832 |
| 2023-03-0116:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-005822 |
| 2023-01-0907:34 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-23-000722 |
| 2023-01-0516:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-000450 |
| 2022-11-0916:18 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001628280-22-029246 |
| 2022-11-0916:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-029232 |
| 2022-10-2816:56 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-22-027328 |
| 2022-09-2708:08 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-22-025522 |
| 2022-08-0916:44 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001628280-22-021975 |
| 2022-08-0916:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-021960 |
| 2022-08-0316:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-211271 |
| 2022-06-2216:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-22-178758 |
| 2022-06-0107:01 ET | 8-K/A | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-22-164558 |
| 2022-05-3108:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-163153 |
| 2022-05-1016:32 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001193125-22-146354 |
| 2022-05-1016:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-146289 |
| 2022-05-0217:06 ET | DEF 14A | Proxy statementPeriod 2022-06-22 | 0001193125-22-136861 |
| 2022-05-0216:31 ET | 8-K/A | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-22-136847 |
| 2022-04-2107:34 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-22-112107 |
| 2022-04-0116:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-093727 |
| 2022-03-2816:06 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-22-086628 |
| 2022-03-1508:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-075434 |
| 2022-03-0116:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-061344 |
| 2022-03-0116:09 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001193125-22-061312 |
| 2022-02-2816:07 ET | DEF 14A | Proxy statementPeriod 2022-03-28 | 0001193125-22-057863 |
| 2022-01-0607:44 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-003149 |
| 2021-12-2216:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-364991 |
| 2021-12-1607:43 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-358580 |
| 2021-12-0307:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-347244 |
| 2021-11-2207:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-335921 |
| 2021-11-0916:26 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001193125-21-324522 |
| 2021-11-0916:07 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001193125-21-324438 |
| 2021-11-0516:14 ET | 8-K | 8.01 Other events | 0001193125-21-321607 |
| 2021-10-2016:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-303048 |
| 2021-10-1909:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-301641 |
| 2021-10-1807:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-300554 |
| 2021-08-0916:08 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001193125-21-240435 |
| 2021-08-0916:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-240429 |
| 2021-06-2416:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-21-198645 |
| 2021-06-1607:43 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-191664 |
| 2021-06-0107:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-177816 |
| 2021-05-1008:58 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001193125-21-155749 |
| 2021-05-1008:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-155746 |
| 2021-04-3016:02 ET | DEF 14A | Proxy statementPeriod 2021-06-24 | 0001193125-21-144949 |
| 2021-04-2312:29 ET | 8-K | 9.01 Financial statements and exhibits | 0001193125-21-128454 |
| 2021-04-2115:00 ET | 8-K | 9.01 Financial statements and exhibits | 0001193125-21-124501 |
| 2021-04-2121:38 ET | 8-K | 9.01 Financial statements and exhibits | 0001193125-21-123323 |
| 2021-04-1916:30 ET | 8-K | 9.01 Financial statements and exhibits | 0001193125-21-121301 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 00:47 ET. Listed shows no prices and gives no investment advice.